Janus Henderson Group plc 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:05 am Sale | 2022-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | JANUS HENDERSON GROUP PLC JHG | 2,415,638 2.500% | -5,030,201 (-67.56%) | Filing |
| 2022-02-10 4:46 pm Sale | 2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | JANUS HENDERSON GROUP PLC JHG | 7,445,839 7.800% | -1,998,282 (-21.16%) | Filing |
| 2021-04-12 2:46 pm Purchase | 2021-03-31 | 13G | Neurocrine Biosciences, Inc. NBIX | JANUS HENDERSON GROUP PLC JHG | 9,444,121 10.000% | 136,201 (+1.46%) | Filing |
| 2021-02-11 4:55 pm Purchase | 2020-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX | JANUS HENDERSON GROUP PLC JHG | 9,307,920 9.900% | 1,934,408 (+26.23%) | Filing |